Mertens Steve 4
4 · NEUROONE MEDICAL TECHNOLOGIES Corp · Filed Apr 21, 2025
Insider Transaction Report
Form 4
Mertens Steve
Chief Technology Officer
Transactions
- Award
Option to Purchase Common Stock
2025-04-17+200,000→ 200,000 totalExercise: $0.58Exp: 2035-04-16→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]25% will vest on April 17, 2026, and the remaining 75% will vest in 12 equal quarterly installments.